SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (5604)9/18/1998 1:18:00 PM
From: N  Read Replies (1) | Respond to of 9523
 
precipitated by years of taking inderal.

sorry about this...one learns assiduously to read the PDR and ask a pharmacist, vigilantly, one of life's sad lessons...

Or as my ma said, M.D.'s...maybe they had pharmacology 20 years ago...



To: flickerful who wrote (5604)9/18/1998 2:50:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
OK, PFE got a plug from Douglas Cliggott from J.P. Morgan on the CNBC segment "Taking Stocks" just now. Verbatim:

"We like Pfizer both short and long term for one key reason: its earnings profile looks terrific."

It's one of his favourite stocks.